Clinical Trial: A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases

U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07593911) titled 'A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases' on May 12.

Brief Summary: This is an investigator-initiated, open-label, single-arm, dose-escalation and dose-expansion study to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of MTM-H-001 in adult participants with B-cell-related autoimmune diseases.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Systemic Lupus Erthematosus (SLE) Lupus Nephritis (LN) Multiple Sclerosis Myasthenia Gravis (MG) IgG4-Related Diseases Rheumatoid Arthritis (RA)

Intervention: DRUG: MTM-H-001 Injection

Each parti...